The Effects of Gastric Acid Suppression on the Colonic Microbiome
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2015
Price : $35 *
At a glance
- Drugs Omeprazole (Primary)
- Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacodynamics
- 13 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 26 Mar 2014 Planned end date changed from 1 Jul 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 26 Mar 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.